nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A5—prostate cancer	0.235	0.698	CbGaD
Oxycodone—CYP3A4—prostate cancer	0.102	0.302	CbGaD
Oxycodone—CYP3A5—Flutamide—prostate cancer	0.0362	0.0912	CbGbCtD
Oxycodone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0324	0.0817	CbGbCtD
Oxycodone—CYP2D6—Bicalutamide—prostate cancer	0.0268	0.0675	CbGbCtD
Oxycodone—CYP3A5—Cabazitaxel—prostate cancer	0.0268	0.0675	CbGbCtD
Oxycodone—CYP3A5—Estrone—prostate cancer	0.0262	0.066	CbGbCtD
Oxycodone—CYP2D6—Abiraterone—prostate cancer	0.0222	0.0559	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.02	0.0505	CbGbCtD
Oxycodone—CYP3A7—Estradiol—prostate cancer	0.02	0.0505	CbGbCtD
Oxycodone—CYP3A4—Bicalutamide—prostate cancer	0.017	0.0429	CbGbCtD
Oxycodone—CYP3A4—Estramustine—prostate cancer	0.0158	0.0399	CbGbCtD
Oxycodone—CYP3A5—Estradiol—prostate cancer	0.015	0.0379	CbGbCtD
Oxycodone—CYP3A4—Abiraterone—prostate cancer	0.0141	0.0356	CbGbCtD
Oxycodone—CYP3A4—Flutamide—prostate cancer	0.0141	0.0356	CbGbCtD
Oxycodone—CYP3A7—Docetaxel—prostate cancer	0.012	0.0302	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.012	0.0302	CbGbCtD
Oxycodone—CYP3A4—Cabazitaxel—prostate cancer	0.0104	0.0263	CbGbCtD
Oxycodone—CYP3A4—Estrone—prostate cancer	0.0102	0.0257	CbGbCtD
Oxycodone—CYP3A5—Etoposide—prostate cancer	0.00982	0.0247	CbGbCtD
Oxycodone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0091	0.0229	CbGbCtD
Oxycodone—CYP3A5—Docetaxel—prostate cancer	0.00898	0.0226	CbGbCtD
Oxycodone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00668	0.0168	CbGbCtD
Oxycodone—CYP3A4—Mitoxantrone—prostate cancer	0.00607	0.0153	CbGbCtD
Oxycodone—CYP3A4—Estradiol—prostate cancer	0.00586	0.0148	CbGbCtD
Oxycodone—CYP3A4—Prednisone—prostate cancer	0.00504	0.0127	CbGbCtD
Oxycodone—CYP2D6—Doxorubicin—prostate cancer	0.00411	0.0103	CbGbCtD
Oxycodone—CYP3A4—Etoposide—prostate cancer	0.00383	0.00965	CbGbCtD
Oxycodone—CYP3A4—Docetaxel—prostate cancer	0.0035	0.00883	CbGbCtD
Oxycodone—CYP3A4—Doxorubicin—prostate cancer	0.00261	0.00658	CbGbCtD
Oxycodone—Naloxone—TLR4—prostate cancer	0.000779	0.257	CrCbGaD
Oxycodone—Galantamine—ACHE—prostate cancer	0.000381	0.126	CrCbGaD
Oxycodone—Codeine—SLC22A1—prostate cancer	0.000333	0.11	CrCbGaD
Oxycodone—Codeine—CYP3A5—prostate cancer	0.000269	0.0886	CrCbGaD
Oxycodone—Naloxone—ESR1—prostate cancer	0.000218	0.0721	CrCbGaD
Oxycodone—Dihydrocodeine—CYP3A4—prostate cancer	0.000174	0.0575	CrCbGaD
Oxycodone—Oxymorphone—CYP3A4—prostate cancer	0.000153	0.0504	CrCbGaD
Oxycodone—Ethylmorphine—CYP3A4—prostate cancer	0.000146	0.0482	CrCbGaD
Oxycodone—Hydrocodone—CYP3A4—prostate cancer	0.000134	0.0441	CrCbGaD
Oxycodone—Codeine—CYP3A4—prostate cancer	0.000116	0.0384	CrCbGaD
Oxycodone—Naloxone—CYP3A4—prostate cancer	0.000111	0.0368	CrCbGaD
Oxycodone—Hydromorphone—CYP3A4—prostate cancer	0.000111	0.0365	CrCbGaD
Oxycodone—Galantamine—CYP3A4—prostate cancer	0.000106	0.0348	CrCbGaD
Oxycodone—Insomnia—Docetaxel—prostate cancer	3.37e-05	0.000182	CcSEcCtD
Oxycodone—Arthralgia—Prednisone—prostate cancer	3.36e-05	0.000181	CcSEcCtD
Oxycodone—Myalgia—Prednisone—prostate cancer	3.36e-05	0.000181	CcSEcCtD
Oxycodone—Paraesthesia—Docetaxel—prostate cancer	3.35e-05	0.00018	CcSEcCtD
Oxycodone—Anxiety—Prednisone—prostate cancer	3.34e-05	0.00018	CcSEcCtD
Oxycodone—Bradycardia—Doxorubicin—prostate cancer	3.34e-05	0.00018	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.33e-05	0.00018	CcSEcCtD
Oxycodone—Dyspnoea—Docetaxel—prostate cancer	3.33e-05	0.000179	CcSEcCtD
Oxycodone—Somnolence—Docetaxel—prostate cancer	3.32e-05	0.000179	CcSEcCtD
Oxycodone—Discomfort—Prednisone—prostate cancer	3.32e-05	0.000179	CcSEcCtD
Oxycodone—Eye disorder—Epirubicin—prostate cancer	3.31e-05	0.000178	CcSEcCtD
Oxycodone—Hypersensitivity—Etoposide—prostate cancer	3.31e-05	0.000178	CcSEcCtD
Oxycodone—Tinnitus—Epirubicin—prostate cancer	3.3e-05	0.000178	CcSEcCtD
Oxycodone—Haemoglobin—Doxorubicin—prostate cancer	3.29e-05	0.000177	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.29e-05	0.000177	CcSEcCtD
Oxycodone—Flushing—Epirubicin—prostate cancer	3.29e-05	0.000177	CcSEcCtD
Oxycodone—Cardiac disorder—Epirubicin—prostate cancer	3.29e-05	0.000177	CcSEcCtD
Oxycodone—Rhinitis—Doxorubicin—prostate cancer	3.29e-05	0.000177	CcSEcCtD
Oxycodone—Dyspepsia—Docetaxel—prostate cancer	3.28e-05	0.000177	CcSEcCtD
Oxycodone—Haemorrhage—Doxorubicin—prostate cancer	3.28e-05	0.000177	CcSEcCtD
Oxycodone—Hepatitis—Doxorubicin—prostate cancer	3.28e-05	0.000177	CcSEcCtD
Oxycodone—Insomnia—Capecitabine—prostate cancer	3.27e-05	0.000176	CcSEcCtD
Oxycodone—Hypoaesthesia—Doxorubicin—prostate cancer	3.26e-05	0.000176	CcSEcCtD
Oxycodone—Pharyngitis—Doxorubicin—prostate cancer	3.25e-05	0.000175	CcSEcCtD
Oxycodone—Paraesthesia—Capecitabine—prostate cancer	3.24e-05	0.000175	CcSEcCtD
Oxycodone—Decreased appetite—Docetaxel—prostate cancer	3.24e-05	0.000175	CcSEcCtD
Oxycodone—Urinary tract disorder—Doxorubicin—prostate cancer	3.24e-05	0.000174	CcSEcCtD
Oxycodone—Oedema peripheral—Doxorubicin—prostate cancer	3.23e-05	0.000174	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Docetaxel—prostate cancer	3.22e-05	0.000173	CcSEcCtD
Oxycodone—Asthenia—Etoposide—prostate cancer	3.22e-05	0.000173	CcSEcCtD
Oxycodone—Connective tissue disorder—Doxorubicin—prostate cancer	3.22e-05	0.000173	CcSEcCtD
Oxycodone—Dyspnoea—Capecitabine—prostate cancer	3.22e-05	0.000173	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisone—prostate cancer	3.22e-05	0.000173	CcSEcCtD
Oxycodone—Oedema—Prednisone—prostate cancer	3.22e-05	0.000173	CcSEcCtD
Oxycodone—Fatigue—Docetaxel—prostate cancer	3.22e-05	0.000173	CcSEcCtD
Oxycodone—Angiopathy—Epirubicin—prostate cancer	3.21e-05	0.000173	CcSEcCtD
Oxycodone—Urethral disorder—Doxorubicin—prostate cancer	3.21e-05	0.000173	CcSEcCtD
Oxycodone—Nausea—Mitoxantrone—prostate cancer	3.21e-05	0.000173	CcSEcCtD
Oxycodone—Immune system disorder—Epirubicin—prostate cancer	3.2e-05	0.000172	CcSEcCtD
Oxycodone—Infection—Prednisone—prostate cancer	3.2e-05	0.000172	CcSEcCtD
Oxycodone—Mediastinal disorder—Epirubicin—prostate cancer	3.19e-05	0.000172	CcSEcCtD
Oxycodone—Pain—Docetaxel—prostate cancer	3.19e-05	0.000172	CcSEcCtD
Oxycodone—Constipation—Docetaxel—prostate cancer	3.19e-05	0.000172	CcSEcCtD
Oxycodone—Dyspepsia—Capecitabine—prostate cancer	3.18e-05	0.000171	CcSEcCtD
Oxycodone—Chills—Epirubicin—prostate cancer	3.18e-05	0.000171	CcSEcCtD
Oxycodone—Pruritus—Etoposide—prostate cancer	3.18e-05	0.000171	CcSEcCtD
Oxycodone—Shock—Prednisone—prostate cancer	3.17e-05	0.000171	CcSEcCtD
Oxycodone—Visual impairment—Doxorubicin—prostate cancer	3.16e-05	0.00017	CcSEcCtD
Oxycodone—Nervous system disorder—Prednisone—prostate cancer	3.16e-05	0.00017	CcSEcCtD
Oxycodone—Tachycardia—Prednisone—prostate cancer	3.14e-05	0.000169	CcSEcCtD
Oxycodone—Decreased appetite—Capecitabine—prostate cancer	3.14e-05	0.000169	CcSEcCtD
Oxycodone—Skin disorder—Prednisone—prostate cancer	3.13e-05	0.000168	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Capecitabine—prostate cancer	3.12e-05	0.000168	CcSEcCtD
Oxycodone—Fatigue—Capecitabine—prostate cancer	3.11e-05	0.000168	CcSEcCtD
Oxycodone—Hyperhidrosis—Prednisone—prostate cancer	3.11e-05	0.000168	CcSEcCtD
Oxycodone—Mental disorder—Epirubicin—prostate cancer	3.1e-05	0.000167	CcSEcCtD
Oxycodone—Constipation—Capecitabine—prostate cancer	3.09e-05	0.000166	CcSEcCtD
Oxycodone—Pain—Capecitabine—prostate cancer	3.09e-05	0.000166	CcSEcCtD
Oxycodone—Malnutrition—Epirubicin—prostate cancer	3.08e-05	0.000166	CcSEcCtD
Oxycodone—Feeling abnormal—Docetaxel—prostate cancer	3.07e-05	0.000166	CcSEcCtD
Oxycodone—Diarrhoea—Etoposide—prostate cancer	3.07e-05	0.000165	CcSEcCtD
Oxycodone—Anorexia—Prednisone—prostate cancer	3.07e-05	0.000165	CcSEcCtD
Oxycodone—Eye disorder—Doxorubicin—prostate cancer	3.06e-05	0.000165	CcSEcCtD
Oxycodone—Tinnitus—Doxorubicin—prostate cancer	3.06e-05	0.000165	CcSEcCtD
Oxycodone—Gastrointestinal pain—Docetaxel—prostate cancer	3.05e-05	0.000164	CcSEcCtD
Oxycodone—Cardiac disorder—Doxorubicin—prostate cancer	3.04e-05	0.000164	CcSEcCtD
Oxycodone—Flushing—Doxorubicin—prostate cancer	3.04e-05	0.000164	CcSEcCtD
Oxycodone—Flatulence—Epirubicin—prostate cancer	3.04e-05	0.000164	CcSEcCtD
Oxycodone—Tension—Epirubicin—prostate cancer	3.03e-05	0.000163	CcSEcCtD
Oxycodone—Dysgeusia—Epirubicin—prostate cancer	3.02e-05	0.000163	CcSEcCtD
Oxycodone—Nervousness—Epirubicin—prostate cancer	2.99e-05	0.000161	CcSEcCtD
Oxycodone—Back pain—Epirubicin—prostate cancer	2.98e-05	0.000161	CcSEcCtD
Oxycodone—Feeling abnormal—Capecitabine—prostate cancer	2.98e-05	0.00016	CcSEcCtD
Oxycodone—Angiopathy—Doxorubicin—prostate cancer	2.97e-05	0.00016	CcSEcCtD
Oxycodone—Dizziness—Etoposide—prostate cancer	2.97e-05	0.00016	CcSEcCtD
Oxycodone—Muscle spasms—Epirubicin—prostate cancer	2.96e-05	0.00016	CcSEcCtD
Oxycodone—Immune system disorder—Doxorubicin—prostate cancer	2.96e-05	0.000159	CcSEcCtD
Oxycodone—Gastrointestinal pain—Capecitabine—prostate cancer	2.95e-05	0.000159	CcSEcCtD
Oxycodone—Mediastinal disorder—Doxorubicin—prostate cancer	2.95e-05	0.000159	CcSEcCtD
Oxycodone—Body temperature increased—Docetaxel—prostate cancer	2.95e-05	0.000159	CcSEcCtD
Oxycodone—Abdominal pain—Docetaxel—prostate cancer	2.95e-05	0.000159	CcSEcCtD
Oxycodone—Chills—Doxorubicin—prostate cancer	2.94e-05	0.000158	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Prednisone—prostate cancer	2.93e-05	0.000158	CcSEcCtD
Oxycodone—Insomnia—Prednisone—prostate cancer	2.91e-05	0.000157	CcSEcCtD
Oxycodone—Paraesthesia—Prednisone—prostate cancer	2.89e-05	0.000156	CcSEcCtD
Oxycodone—Mental disorder—Doxorubicin—prostate cancer	2.87e-05	0.000155	CcSEcCtD
Oxycodone—Urticaria—Capecitabine—prostate cancer	2.87e-05	0.000155	CcSEcCtD
Oxycodone—Ill-defined disorder—Epirubicin—prostate cancer	2.86e-05	0.000154	CcSEcCtD
Oxycodone—Body temperature increased—Capecitabine—prostate cancer	2.86e-05	0.000154	CcSEcCtD
Oxycodone—Abdominal pain—Capecitabine—prostate cancer	2.86e-05	0.000154	CcSEcCtD
Oxycodone—Vomiting—Etoposide—prostate cancer	2.85e-05	0.000154	CcSEcCtD
Oxycodone—Malnutrition—Doxorubicin—prostate cancer	2.85e-05	0.000154	CcSEcCtD
Oxycodone—Anaemia—Epirubicin—prostate cancer	2.85e-05	0.000154	CcSEcCtD
Oxycodone—Agitation—Epirubicin—prostate cancer	2.83e-05	0.000153	CcSEcCtD
Oxycodone—Dyspepsia—Prednisone—prostate cancer	2.83e-05	0.000153	CcSEcCtD
Oxycodone—Rash—Etoposide—prostate cancer	2.83e-05	0.000152	CcSEcCtD
Oxycodone—Dermatitis—Etoposide—prostate cancer	2.83e-05	0.000152	CcSEcCtD
Oxycodone—Headache—Etoposide—prostate cancer	2.81e-05	0.000151	CcSEcCtD
Oxycodone—Flatulence—Doxorubicin—prostate cancer	2.81e-05	0.000151	CcSEcCtD
Oxycodone—Tension—Doxorubicin—prostate cancer	2.8e-05	0.000151	CcSEcCtD
Oxycodone—Decreased appetite—Prednisone—prostate cancer	2.8e-05	0.000151	CcSEcCtD
Oxycodone—Dysgeusia—Doxorubicin—prostate cancer	2.79e-05	0.00015	CcSEcCtD
Oxycodone—Malaise—Epirubicin—prostate cancer	2.78e-05	0.00015	CcSEcCtD
Oxycodone—Fatigue—Prednisone—prostate cancer	2.77e-05	0.000149	CcSEcCtD
Oxycodone—Nervousness—Doxorubicin—prostate cancer	2.77e-05	0.000149	CcSEcCtD
Oxycodone—Vertigo—Epirubicin—prostate cancer	2.77e-05	0.000149	CcSEcCtD
Oxycodone—Syncope—Epirubicin—prostate cancer	2.77e-05	0.000149	CcSEcCtD
Oxycodone—Leukopenia—Epirubicin—prostate cancer	2.76e-05	0.000149	CcSEcCtD
Oxycodone—Back pain—Doxorubicin—prostate cancer	2.76e-05	0.000149	CcSEcCtD
Oxycodone—Constipation—Prednisone—prostate cancer	2.75e-05	0.000148	CcSEcCtD
Oxycodone—Hypersensitivity—Docetaxel—prostate cancer	2.75e-05	0.000148	CcSEcCtD
Oxycodone—Muscle spasms—Doxorubicin—prostate cancer	2.74e-05	0.000148	CcSEcCtD
Oxycodone—Palpitations—Epirubicin—prostate cancer	2.72e-05	0.000147	CcSEcCtD
Oxycodone—Loss of consciousness—Epirubicin—prostate cancer	2.71e-05	0.000146	CcSEcCtD
Oxycodone—Cough—Epirubicin—prostate cancer	2.69e-05	0.000145	CcSEcCtD
Oxycodone—Asthenia—Docetaxel—prostate cancer	2.68e-05	0.000144	CcSEcCtD
Oxycodone—Convulsion—Epirubicin—prostate cancer	2.67e-05	0.000144	CcSEcCtD
Oxycodone—Nausea—Etoposide—prostate cancer	2.67e-05	0.000144	CcSEcCtD
Oxycodone—Hypersensitivity—Capecitabine—prostate cancer	2.66e-05	0.000143	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisone—prostate cancer	2.65e-05	0.000143	CcSEcCtD
Oxycodone—Ill-defined disorder—Doxorubicin—prostate cancer	2.65e-05	0.000143	CcSEcCtD
Oxycodone—Pruritus—Docetaxel—prostate cancer	2.64e-05	0.000142	CcSEcCtD
Oxycodone—Anaemia—Doxorubicin—prostate cancer	2.64e-05	0.000142	CcSEcCtD
Oxycodone—Gastrointestinal pain—Prednisone—prostate cancer	2.63e-05	0.000142	CcSEcCtD
Oxycodone—Myalgia—Epirubicin—prostate cancer	2.63e-05	0.000141	CcSEcCtD
Oxycodone—Arthralgia—Epirubicin—prostate cancer	2.63e-05	0.000141	CcSEcCtD
Oxycodone—Chest pain—Epirubicin—prostate cancer	2.63e-05	0.000141	CcSEcCtD
Oxycodone—Agitation—Doxorubicin—prostate cancer	2.62e-05	0.000141	CcSEcCtD
Oxycodone—Anxiety—Epirubicin—prostate cancer	2.62e-05	0.000141	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.61e-05	0.00014	CcSEcCtD
Oxycodone—Discomfort—Epirubicin—prostate cancer	2.59e-05	0.00014	CcSEcCtD
Oxycodone—Asthenia—Capecitabine—prostate cancer	2.59e-05	0.00014	CcSEcCtD
Oxycodone—Malaise—Doxorubicin—prostate cancer	2.57e-05	0.000139	CcSEcCtD
Oxycodone—Dry mouth—Epirubicin—prostate cancer	2.57e-05	0.000138	CcSEcCtD
Oxycodone—Vertigo—Doxorubicin—prostate cancer	2.56e-05	0.000138	CcSEcCtD
Oxycodone—Syncope—Doxorubicin—prostate cancer	2.56e-05	0.000138	CcSEcCtD
Oxycodone—Urticaria—Prednisone—prostate cancer	2.56e-05	0.000138	CcSEcCtD
Oxycodone—Pruritus—Capecitabine—prostate cancer	2.56e-05	0.000138	CcSEcCtD
Oxycodone—Leukopenia—Doxorubicin—prostate cancer	2.55e-05	0.000138	CcSEcCtD
Oxycodone—Diarrhoea—Docetaxel—prostate cancer	2.55e-05	0.000137	CcSEcCtD
Oxycodone—Body temperature increased—Prednisone—prostate cancer	2.54e-05	0.000137	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—prostate cancer	2.54e-05	0.000137	CcSEcCtD
Oxycodone—Confusional state—Epirubicin—prostate cancer	2.54e-05	0.000137	CcSEcCtD
Oxycodone—Palpitations—Doxorubicin—prostate cancer	2.52e-05	0.000136	CcSEcCtD
Oxycodone—Anaphylactic shock—Epirubicin—prostate cancer	2.52e-05	0.000136	CcSEcCtD
Oxycodone—Oedema—Epirubicin—prostate cancer	2.52e-05	0.000136	CcSEcCtD
Oxycodone—Loss of consciousness—Doxorubicin—prostate cancer	2.51e-05	0.000135	CcSEcCtD
Oxycodone—Infection—Epirubicin—prostate cancer	2.5e-05	0.000135	CcSEcCtD
Oxycodone—Cough—Doxorubicin—prostate cancer	2.49e-05	0.000134	CcSEcCtD
Oxycodone—Shock—Epirubicin—prostate cancer	2.48e-05	0.000133	CcSEcCtD
Oxycodone—Convulsion—Doxorubicin—prostate cancer	2.47e-05	0.000133	CcSEcCtD
Oxycodone—Diarrhoea—Capecitabine—prostate cancer	2.47e-05	0.000133	CcSEcCtD
Oxycodone—Nervous system disorder—Epirubicin—prostate cancer	2.47e-05	0.000133	CcSEcCtD
Oxycodone—Dizziness—Docetaxel—prostate cancer	2.47e-05	0.000133	CcSEcCtD
Oxycodone—Tachycardia—Epirubicin—prostate cancer	2.46e-05	0.000132	CcSEcCtD
Oxycodone—Skin disorder—Epirubicin—prostate cancer	2.44e-05	0.000132	CcSEcCtD
Oxycodone—Hyperhidrosis—Epirubicin—prostate cancer	2.43e-05	0.000131	CcSEcCtD
Oxycodone—Chest pain—Doxorubicin—prostate cancer	2.43e-05	0.000131	CcSEcCtD
Oxycodone—Arthralgia—Doxorubicin—prostate cancer	2.43e-05	0.000131	CcSEcCtD
Oxycodone—Myalgia—Doxorubicin—prostate cancer	2.43e-05	0.000131	CcSEcCtD
Oxycodone—Anxiety—Doxorubicin—prostate cancer	2.42e-05	0.00013	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.41e-05	0.00013	CcSEcCtD
Oxycodone—Discomfort—Doxorubicin—prostate cancer	2.4e-05	0.000129	CcSEcCtD
Oxycodone—Anorexia—Epirubicin—prostate cancer	2.4e-05	0.000129	CcSEcCtD
Oxycodone—Dizziness—Capecitabine—prostate cancer	2.39e-05	0.000129	CcSEcCtD
Oxycodone—Dry mouth—Doxorubicin—prostate cancer	2.38e-05	0.000128	CcSEcCtD
Oxycodone—Vomiting—Docetaxel—prostate cancer	2.37e-05	0.000128	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisone—prostate cancer	2.37e-05	0.000128	CcSEcCtD
Oxycodone—Rash—Docetaxel—prostate cancer	2.35e-05	0.000127	CcSEcCtD
Oxycodone—Hypotension—Epirubicin—prostate cancer	2.35e-05	0.000127	CcSEcCtD
Oxycodone—Dermatitis—Docetaxel—prostate cancer	2.35e-05	0.000127	CcSEcCtD
Oxycodone—Confusional state—Doxorubicin—prostate cancer	2.35e-05	0.000126	CcSEcCtD
Oxycodone—Headache—Docetaxel—prostate cancer	2.34e-05	0.000126	CcSEcCtD
Oxycodone—Anaphylactic shock—Doxorubicin—prostate cancer	2.33e-05	0.000125	CcSEcCtD
Oxycodone—Oedema—Doxorubicin—prostate cancer	2.33e-05	0.000125	CcSEcCtD
Oxycodone—Infection—Doxorubicin—prostate cancer	2.31e-05	0.000125	CcSEcCtD
Oxycodone—Asthenia—Prednisone—prostate cancer	2.31e-05	0.000124	CcSEcCtD
Oxycodone—Vomiting—Capecitabine—prostate cancer	2.3e-05	0.000124	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.29e-05	0.000123	CcSEcCtD
Oxycodone—Shock—Doxorubicin—prostate cancer	2.29e-05	0.000123	CcSEcCtD
Oxycodone—Nervous system disorder—Doxorubicin—prostate cancer	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Rash—Capecitabine—prostate cancer	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Pruritus—Prednisone—prostate cancer	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Insomnia—Epirubicin—prostate cancer	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Dermatitis—Capecitabine—prostate cancer	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Tachycardia—Doxorubicin—prostate cancer	2.27e-05	0.000122	CcSEcCtD
Oxycodone—Headache—Capecitabine—prostate cancer	2.26e-05	0.000122	CcSEcCtD
Oxycodone—Skin disorder—Doxorubicin—prostate cancer	2.26e-05	0.000122	CcSEcCtD
Oxycodone—Paraesthesia—Epirubicin—prostate cancer	2.26e-05	0.000122	CcSEcCtD
Oxycodone—Hyperhidrosis—Doxorubicin—prostate cancer	2.25e-05	0.000121	CcSEcCtD
Oxycodone—Dyspnoea—Epirubicin—prostate cancer	2.24e-05	0.000121	CcSEcCtD
Oxycodone—Somnolence—Epirubicin—prostate cancer	2.24e-05	0.000121	CcSEcCtD
Oxycodone—Anorexia—Doxorubicin—prostate cancer	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Nausea—Docetaxel—prostate cancer	2.22e-05	0.000119	CcSEcCtD
Oxycodone—Dyspepsia—Epirubicin—prostate cancer	2.22e-05	0.000119	CcSEcCtD
Oxycodone—Diarrhoea—Prednisone—prostate cancer	2.2e-05	0.000119	CcSEcCtD
Oxycodone—Decreased appetite—Epirubicin—prostate cancer	2.19e-05	0.000118	CcSEcCtD
Oxycodone—Hypotension—Doxorubicin—prostate cancer	2.18e-05	0.000117	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.17e-05	0.000117	CcSEcCtD
Oxycodone—Fatigue—Epirubicin—prostate cancer	2.17e-05	0.000117	CcSEcCtD
Oxycodone—Constipation—Epirubicin—prostate cancer	2.15e-05	0.000116	CcSEcCtD
Oxycodone—Pain—Epirubicin—prostate cancer	2.15e-05	0.000116	CcSEcCtD
Oxycodone—Nausea—Capecitabine—prostate cancer	2.15e-05	0.000116	CcSEcCtD
Oxycodone—Dizziness—Prednisone—prostate cancer	2.13e-05	0.000115	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.12e-05	0.000114	CcSEcCtD
Oxycodone—Insomnia—Doxorubicin—prostate cancer	2.11e-05	0.000113	CcSEcCtD
Oxycodone—Paraesthesia—Doxorubicin—prostate cancer	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Dyspnoea—Doxorubicin—prostate cancer	2.08e-05	0.000112	CcSEcCtD
Oxycodone—Feeling abnormal—Epirubicin—prostate cancer	2.07e-05	0.000112	CcSEcCtD
Oxycodone—Somnolence—Doxorubicin—prostate cancer	2.07e-05	0.000111	CcSEcCtD
Oxycodone—Gastrointestinal pain—Epirubicin—prostate cancer	2.06e-05	0.000111	CcSEcCtD
Oxycodone—Dyspepsia—Doxorubicin—prostate cancer	2.05e-05	0.00011	CcSEcCtD
Oxycodone—Vomiting—Prednisone—prostate cancer	2.05e-05	0.00011	CcSEcCtD
Oxycodone—Rash—Prednisone—prostate cancer	2.03e-05	0.000109	CcSEcCtD
Oxycodone—Dermatitis—Prednisone—prostate cancer	2.03e-05	0.000109	CcSEcCtD
Oxycodone—Decreased appetite—Doxorubicin—prostate cancer	2.02e-05	0.000109	CcSEcCtD
Oxycodone—Headache—Prednisone—prostate cancer	2.02e-05	0.000109	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.01e-05	0.000108	CcSEcCtD
Oxycodone—Fatigue—Doxorubicin—prostate cancer	2.01e-05	0.000108	CcSEcCtD
Oxycodone—Urticaria—Epirubicin—prostate cancer	2e-05	0.000108	CcSEcCtD
Oxycodone—Pain—Doxorubicin—prostate cancer	1.99e-05	0.000107	CcSEcCtD
Oxycodone—Constipation—Doxorubicin—prostate cancer	1.99e-05	0.000107	CcSEcCtD
Oxycodone—Abdominal pain—Epirubicin—prostate cancer	1.99e-05	0.000107	CcSEcCtD
Oxycodone—Body temperature increased—Epirubicin—prostate cancer	1.99e-05	0.000107	CcSEcCtD
Oxycodone—Feeling abnormal—Doxorubicin—prostate cancer	1.92e-05	0.000103	CcSEcCtD
Oxycodone—Nausea—Prednisone—prostate cancer	1.91e-05	0.000103	CcSEcCtD
Oxycodone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.9e-05	0.000103	CcSEcCtD
Oxycodone—Hypersensitivity—Epirubicin—prostate cancer	1.85e-05	9.99e-05	CcSEcCtD
Oxycodone—Urticaria—Doxorubicin—prostate cancer	1.85e-05	9.96e-05	CcSEcCtD
Oxycodone—Body temperature increased—Doxorubicin—prostate cancer	1.84e-05	9.91e-05	CcSEcCtD
Oxycodone—Abdominal pain—Doxorubicin—prostate cancer	1.84e-05	9.91e-05	CcSEcCtD
Oxycodone—Asthenia—Epirubicin—prostate cancer	1.81e-05	9.73e-05	CcSEcCtD
Oxycodone—Pruritus—Epirubicin—prostate cancer	1.78e-05	9.59e-05	CcSEcCtD
Oxycodone—Diarrhoea—Epirubicin—prostate cancer	1.72e-05	9.27e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Doxorubicin—prostate cancer	1.72e-05	9.24e-05	CcSEcCtD
Oxycodone—Asthenia—Doxorubicin—prostate cancer	1.67e-05	9e-05	CcSEcCtD
Oxycodone—Dizziness—Epirubicin—prostate cancer	1.66e-05	8.96e-05	CcSEcCtD
Oxycodone—Pruritus—Doxorubicin—prostate cancer	1.65e-05	8.87e-05	CcSEcCtD
Oxycodone—Vomiting—Epirubicin—prostate cancer	1.6e-05	8.62e-05	CcSEcCtD
Oxycodone—Diarrhoea—Doxorubicin—prostate cancer	1.59e-05	8.58e-05	CcSEcCtD
Oxycodone—Rash—Epirubicin—prostate cancer	1.59e-05	8.55e-05	CcSEcCtD
Oxycodone—Dermatitis—Epirubicin—prostate cancer	1.59e-05	8.54e-05	CcSEcCtD
Oxycodone—Headache—Epirubicin—prostate cancer	1.58e-05	8.49e-05	CcSEcCtD
Oxycodone—Dizziness—Doxorubicin—prostate cancer	1.54e-05	8.29e-05	CcSEcCtD
Oxycodone—Nausea—Epirubicin—prostate cancer	1.49e-05	8.05e-05	CcSEcCtD
Oxycodone—Vomiting—Doxorubicin—prostate cancer	1.48e-05	7.97e-05	CcSEcCtD
Oxycodone—Rash—Doxorubicin—prostate cancer	1.47e-05	7.91e-05	CcSEcCtD
Oxycodone—Dermatitis—Doxorubicin—prostate cancer	1.47e-05	7.9e-05	CcSEcCtD
Oxycodone—Headache—Doxorubicin—prostate cancer	1.46e-05	7.86e-05	CcSEcCtD
Oxycodone—Nausea—Doxorubicin—prostate cancer	1.38e-05	7.45e-05	CcSEcCtD
Oxycodone—CYP3A4—Metabolism—TCN2—prostate cancer	4.93e-06	6.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA3—prostate cancer	4.93e-06	6.3e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—prostate cancer	4.93e-06	6.29e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2A6—prostate cancer	4.91e-06	6.28e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CAV1—prostate cancer	4.88e-06	6.24e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREBBP—prostate cancer	4.88e-06	6.23e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—COMT—prostate cancer	4.87e-06	6.22e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—prostate cancer	4.85e-06	6.19e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JAK2—prostate cancer	4.84e-06	6.18e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—prostate cancer	4.83e-06	6.17e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—prostate cancer	4.82e-06	6.15e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—prostate cancer	4.79e-06	6.12e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKR1C3—prostate cancer	4.78e-06	6.1e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ITPR1—prostate cancer	4.77e-06	6.09e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PRKACB—prostate cancer	4.75e-06	6.07e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—prostate cancer	4.75e-06	6.06e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MDM2—prostate cancer	4.73e-06	6.04e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP17A1—prostate cancer	4.71e-06	6.01e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—prostate cancer	4.7e-06	6.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.7e-06	6.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.7e-06	6.01e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB2—prostate cancer	4.66e-06	5.95e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAP2K1—prostate cancer	4.66e-06	5.95e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CD—prostate cancer	4.63e-06	5.91e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CB—prostate cancer	4.6e-06	5.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BAD—prostate cancer	4.59e-06	5.86e-05	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—prostate cancer	4.58e-06	5.85e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SERPINE1—prostate cancer	4.58e-06	5.84e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—prostate cancer	4.57e-06	5.84e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—prostate cancer	4.53e-06	5.78e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.51e-06	5.76e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA4—prostate cancer	4.51e-06	5.76e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TYMS—prostate cancer	4.5e-06	5.75e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOA2—prostate cancer	4.48e-06	5.73e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—prostate cancer	4.45e-06	5.69e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	4.45e-06	5.68e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APC—prostate cancer	4.45e-06	5.68e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGF2—prostate cancer	4.43e-06	5.66e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—prostate cancer	4.42e-06	5.64e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS1—prostate cancer	4.4e-06	5.61e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGF—prostate cancer	4.4e-06	5.61e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA2—prostate cancer	4.39e-06	5.61e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LPL—prostate cancer	4.37e-06	5.58e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOS3—prostate cancer	4.37e-06	5.58e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG5—prostate cancer	4.34e-06	5.54e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.34e-06	5.54e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—INS—prostate cancer	4.33e-06	5.53e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	4.32e-06	5.51e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.28e-06	5.46e-05	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	4.27e-06	5.45e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GSK3B—prostate cancer	4.27e-06	5.45e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JAK2—prostate cancer	4.25e-06	5.42e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CREBBP—prostate cancer	4.24e-06	5.42e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA1—prostate cancer	4.24e-06	5.41e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—prostate cancer	4.23e-06	5.4e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—prostate cancer	4.22e-06	5.39e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1A1—prostate cancer	4.22e-06	5.39e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—INS—prostate cancer	4.21e-06	5.38e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—prostate cancer	4.2e-06	5.37e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NAT2—prostate cancer	4.19e-06	5.35e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTO1—prostate cancer	4.19e-06	5.35e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.19e-06	5.35e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ERCC2—prostate cancer	4.19e-06	5.35e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.18e-06	5.34e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	4.16e-06	5.31e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MDM2—prostate cancer	4.14e-06	5.29e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NQO1—prostate cancer	4.13e-06	5.28e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREBBP—prostate cancer	4.12e-06	5.27e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—prostate cancer	4.12e-06	5.26e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB2—prostate cancer	4.09e-06	5.22e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	4.08e-06	5.21e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—prostate cancer	4.07e-06	5.2e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TH—prostate cancer	4.07e-06	5.2e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—prostate cancer	4.05e-06	5.17e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	4.03e-06	5.15e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.03e-06	5.15e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CD—prostate cancer	4.02e-06	5.14e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLCB2—prostate cancer	4.02e-06	5.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LRP2—prostate cancer	4.02e-06	5.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.02e-06	5.13e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—prostate cancer	4e-06	5.1e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	3.98e-06	5.09e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTEN—prostate cancer	3.97e-06	5.07e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.96e-06	5.06e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—P4HB—prostate cancer	3.94e-06	5.03e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	3.94e-06	5.03e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—prostate cancer	3.94e-06	5.03e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	3.91e-06	4.99e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—prostate cancer	3.88e-06	4.95e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—prostate cancer	3.87e-06	4.95e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	3.87e-06	4.95e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	3.87e-06	4.94e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARA—prostate cancer	3.86e-06	4.93e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GGT1—prostate cancer	3.84e-06	4.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.83e-06	4.9e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—prostate cancer	3.83e-06	4.89e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NOS3—prostate cancer	3.8e-06	4.85e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EP300—prostate cancer	3.79e-06	4.84e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	3.78e-06	4.83e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOA1—prostate cancer	3.78e-06	4.83e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF2—prostate cancer	3.74e-06	4.78e-05	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	3.74e-06	4.78e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.74e-06	4.77e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.72e-06	4.76e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—prostate cancer	3.71e-06	4.74e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—prostate cancer	3.7e-06	4.73e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOS3—prostate cancer	3.69e-06	4.71e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SRC—prostate cancer	3.68e-06	4.71e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—prostate cancer	3.68e-06	4.71e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MED12—prostate cancer	3.68e-06	4.69e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNG5—prostate cancer	3.65e-06	4.66e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAV1—prostate cancer	3.63e-06	4.64e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—prostate cancer	3.61e-06	4.61e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—RXRA—prostate cancer	3.59e-06	4.59e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—prostate cancer	3.59e-06	4.58e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JAK2—prostate cancer	3.59e-06	4.58e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	3.57e-06	4.57e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—prostate cancer	3.55e-06	4.54e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	3.52e-06	4.49e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOA3—prostate cancer	3.51e-06	4.49e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CB—prostate cancer	3.5e-06	4.48e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—prostate cancer	3.5e-06	4.48e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MDM2—prostate cancer	3.5e-06	4.47e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	3.49e-06	4.46e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTEN—prostate cancer	3.48e-06	4.45e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—prostate cancer	3.47e-06	4.44e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—COMT—prostate cancer	3.46e-06	4.42e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB2—prostate cancer	3.45e-06	4.41e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—prostate cancer	3.45e-06	4.4e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	3.41e-06	4.35e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—prostate cancer	3.4e-06	4.34e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ITPR1—prostate cancer	3.39e-06	4.33e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HPGDS—prostate cancer	3.35e-06	4.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.33e-06	4.25e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EP300—prostate cancer	3.32e-06	4.24e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.31e-06	4.22e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—prostate cancer	3.3e-06	4.22e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—prostate cancer	3.29e-06	4.21e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—prostate cancer	3.27e-06	4.18e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—prostate cancer	3.25e-06	4.15e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ACHE—prostate cancer	3.25e-06	4.15e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SRC—prostate cancer	3.23e-06	4.13e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—prostate cancer	3.23e-06	4.12e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.21e-06	4.1e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TYMS—prostate cancer	3.2e-06	4.09e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	3.2e-06	4.08e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—prostate cancer	3.17e-06	4.04e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	3.16e-06	4.04e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—prostate cancer	3.15e-06	4.02e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—prostate cancer	3.13e-06	4e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—INS—prostate cancer	3.13e-06	4e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—prostate cancer	3.13e-06	4e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.13e-06	3.99e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—prostate cancer	3.12e-06	3.98e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—prostate cancer	3.11e-06	3.98e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PRKACB—prostate cancer	3.11e-06	3.97e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LPL—prostate cancer	3.11e-06	3.97e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.08e-06	3.93e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CREBBP—prostate cancer	3.07e-06	3.92e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—prostate cancer	3.05e-06	3.9e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—prostate cancer	3.05e-06	3.9e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTEN—prostate cancer	3.03e-06	3.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	3.02e-06	3.86e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1A1—prostate cancer	3e-06	3.83e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ERCC2—prostate cancer	2.98e-06	3.8e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—prostate cancer	2.96e-06	3.78e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	2.95e-06	3.77e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTEN—prostate cancer	2.94e-06	3.76e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOA2—prostate cancer	2.93e-06	3.74e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.91e-06	3.71e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—prostate cancer	2.9e-06	3.7e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—EP300—prostate cancer	2.89e-06	3.69e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—prostate cancer	2.89e-06	3.69e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—prostate cancer	2.87e-06	3.67e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—prostate cancer	2.83e-06	3.62e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EP300—prostate cancer	2.81e-06	3.59e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	2.8e-06	3.58e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—prostate cancer	2.8e-06	3.57e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.8e-06	3.57e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARA—prostate cancer	2.75e-06	3.51e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NOS3—prostate cancer	2.74e-06	3.51e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.73e-06	3.49e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SRC—prostate cancer	2.73e-06	3.49e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—prostate cancer	2.71e-06	3.46e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NQO1—prostate cancer	2.7e-06	3.45e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—prostate cancer	2.68e-06	3.42e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TH—prostate cancer	2.66e-06	3.4e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—prostate cancer	2.66e-06	3.4e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—prostate cancer	2.63e-06	3.36e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.59e-06	3.31e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAV1—prostate cancer	2.58e-06	3.3e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.53e-06	3.24e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—prostate cancer	2.51e-06	3.21e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GGT1—prostate cancer	2.51e-06	3.2e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—prostate cancer	2.48e-06	3.17e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOA1—prostate cancer	2.47e-06	3.16e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	2.46e-06	3.14e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—prostate cancer	2.45e-06	3.13e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—prostate cancer	2.44e-06	3.12e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.43e-06	3.11e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—prostate cancer	2.39e-06	3.06e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—prostate cancer	2.38e-06	3.04e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.35e-06	3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RXRA—prostate cancer	2.35e-06	3e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—prostate cancer	2.29e-06	2.92e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—COMT—prostate cancer	2.26e-06	2.89e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—prostate cancer	2.26e-06	2.89e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—prostate cancer	2.25e-06	2.88e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—INS—prostate cancer	2.23e-06	2.84e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ITPR1—prostate cancer	2.22e-06	2.83e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTEN—prostate cancer	2.19e-06	2.8e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CREBBP—prostate cancer	2.18e-06	2.78e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—prostate cancer	2.18e-06	2.78e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—prostate cancer	2.14e-06	2.73e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TYMS—prostate cancer	2.09e-06	2.67e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—EP300—prostate cancer	2.09e-06	2.67e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	2.08e-06	2.65e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—prostate cancer	2.07e-06	2.64e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.07e-06	2.64e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPL—prostate cancer	2.03e-06	2.6e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—prostate cancer	2.01e-06	2.57e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—prostate cancer	2.01e-06	2.56e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.96e-06	2.51e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NOS3—prostate cancer	1.95e-06	2.49e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.95e-06	2.49e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—prostate cancer	1.84e-06	2.35e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.83e-06	2.34e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.8e-06	2.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARA—prostate cancer	1.79e-06	2.29e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.79e-06	2.28e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—prostate cancer	1.75e-06	2.23e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.7e-06	2.17e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAV1—prostate cancer	1.69e-06	2.16e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTEN—prostate cancer	1.56e-06	1.99e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.54e-06	1.97e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.54e-06	1.96e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—EP300—prostate cancer	1.48e-06	1.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—INS—prostate cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.43e-06	1.82e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.35e-06	1.73e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NOS3—prostate cancer	1.28e-06	1.63e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—prostate cancer	1.26e-06	1.61e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.18e-06	1.5e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—prostate cancer	1.17e-06	1.49e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.1e-06	1.4e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTEN—prostate cancer	1.02e-06	1.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EP300—prostate cancer	9.71e-07	1.24e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—prostate cancer	8.97e-07	1.15e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.18e-07	9.17e-06	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—prostate cancer	5.87e-07	7.49e-06	CbGpPWpGaD
